$5.17
0.7617.23%
At Close: -
$5.30
0.132.51%
After Hours: 7:55 PM EDT
15 minutes delayed
Monopar Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Monopar Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-0.50 | $-0.45 | -11.1 % |
Mar 2024 | 2024-05-09 | $-0.50 | $-0.70 | 28.6 % |
Dec 2023 | 2024-03-28 | $-0.60 | $-0.75 | 20.0 % |
Sep 2023 | 2023-11-09 | $-0.70 | $-0.85 | 17.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Monopar Therapeutics (MNPR) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-0.50, which missed the estimate of $-0.45.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.